Dr. Bruce Edward Silverstein, MD

Dr. Silverstein practices at Larkspur Optometry in Redding, California.

Dr. Silverstein's NPI, 1255326476, was assigned on September 14, 2005. Dr. Silverstein graduated from Vagelos College of Physicians and Surgeons in 1991. Dr. Silverstein holds California license G76457.

Dr. Silverstein's primary practice is Larkspur Optometry, at 900 Butte St, Redding, CA 96001 in Shasta County. The practice phone is (530) 223-2500.

Dr. Silverstein's primary practice is Larkspur Optometry in Redding, California. Dmand AI also links Dr. Silverstein to 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Silverstein practices. Vendor and product names are available with a free account.

Ophthalmology is Dr. Silverstein's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Silverstein is board certified in ophthalmology by the American Board of Ophthalmology. Dmand AI has Dr. Silverstein's licenses on file in 2 states: California and Florida.

Dmand AI lists age-related macular degeneration, cataract, cataract surgery with lens implant, cold sores or genital herpes, conjunctivitis, dry eye, eye infection or inflammation and eyelid inflammation among the conditions Dr. Silverstein treats.

CMS data shows 18,537 Medicare services from Dr. Silverstein across 23 procedure codes in 2024, for 2,039 Medicare patients. Medicare paid $2,644,440 for them.

CMS counts 2,039 Medicare patients who saw Dr. Silverstein in 2024. The largest group is 75 to 84, with 876 patients. 75% of them have high cholesterol, and 72% have high blood pressure. 15% are also on Medicaid. Their average risk score is 1.09, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Silverstein's median patient age at 75, with 56% women.

In 2024, Dr. Silverstein wrote 2,449 Medicare Part D claims for 780 patients. 59% of them were for generic drugs. CMS names the drug for 2,371 of them, across 25 drugs with 11 or more claims each, at $148,233 in total drug cost. In 2023, CMS named 2,025 claims across 22 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 83 out of 100 for Dr. Silverstein for performance year 2024, reported as part of a group. Dr. Silverstein accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 834 procedures of cataract surgery by Dr. Silverstein, more than 98% of the clinicians it reports for that procedure.

Dmand AI links 8 papers to Dr. Silverstein, published from 2010 to 2022. 2010 was the busiest year, with 3. The most frequent topics are Anti-Bacterial Agents, Conjunctivitis, Bacterial and Double-Blind Method. Dr. Silverstein's most frequent co-authors are Daniel Ho, MD, Alan Koff and Gail L. Torkildsen, MD.

Dmand AI links Dr. Silverstein to 7 clinical trials, 2 of them phase 3 studies. Conditions studied include Cataract, Lens Diseases and Conjunctivitis, Bacterial. Bausch & Lomb Incorporated sponsors the most, 2. Open Payments lists research payments to Dr. Silverstein that name 2 trials.

CMS Open Payments shows 123 general payments to Dr. Silverstein from 28 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 67% of the total. Kala Pharmaceuticals, Inc. paid the most, $2,434. It also lists 9 research payments totaling $289,247 from 2018 to 2020, naming 2 clinical trials.

Dr. Silverstein graduated from Vagelos College of Physicians and Surgeons in 1991.

Dr. Silverstein is in network with 15 carriers, including Elevance, Excellus BlueCross BlueShield and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.